Читать «Будущее медицины: Ваше здоровье в ваших руках» онлайн - страница 233

77. "Irresistible Force Meets Immoveable Object," Nature Biotechnology 32, no. 1 (2014): 1.

78. D. Dobbs, "The F.D.A. vs. Personal Genetic Testing," New Yorker, November 27, 2013, http://www.newyorker.com/online/blogs/elements/2013/11/the-fda-vs-personal-genetic-testing.html?printable=true&currentPage=all.

79. G. Marchant, "The FDA Could Set Personal Genetics Rights Back Decades," Slate, November 26, 2013, http://www.slate.com/articles/technology/future_tense /2013/11/_23andme_fda_letter_premarket_approval_ requirement_could_kill_at_home_genetic.html.

80. U. Francke et al., "Dealing with the Unexpected: Consumer Responses to Direct-Access BRCA Mutation Testing," PeerJ, February 12, 2013, https://peerj.com/articles/8/.

81. R. Epstein, "The FDA Strikes Again: Its Ban on Home Testing Kits Is, as Usual, Likely to Do More Harm Than Good," Point of Law, November 27, 2013: http://www.pointoflaw.com/archives/2013/11/t.php.

82. A. Wolfe, "Anne Wojcicki's Quest for Better Health Care," Wall Street Journal, June 27, 2014, http://online.wsj.com/articles/anne-wojcickis-quest-for-better-health-care-1403892088.

83. C. Bloss, N. Schork, and E. Topol, "Effect of Direct-to-Consumer Genomewide Profiling to Assess Disease Risk," New England Journal of Medicine 364, no. 6 (2011): 524–534.

84. R. C. Green and N. A. Farahany, "The FDA Is Overcautious on Consumer Genomics," Nature 505 (2014): 2.

85. R. Leuty, "23andMe's Andy Page Gets Disruptive with the Masses," San Francisco Business Times, October 22, 2013, http://www.bizjournals.com/sanfrancisco/blog/biotech/ 2013/10/23andme-andy-page-anne-wojcicki.html?page=all.

86. N. Fliesler, "Direct-to-Consumer Genetic Testing: A Case of Potential Harm," Boston Children's Hospital science and clinical innovation blog, May 5, 2014, http://vectorblog.org/2014/05/direct-to-consumer-genetic-testing-a-case-of-potential-harm/.

87. S. Pasha, "23andMe Revealed a Condition It Took My Doctors Six Years to Diagnose," Quartz, November 28, 2013, http://qz.com/151817/23andme-revealed-a-condition-it-took-my-doctors-six-years-to-diagnose/.

88. "The FDA and Thee," Wall Street Journal, November 25, 2013: http://online.wsj.com/news/articles/SB10001424052702304465604579220003539640102.

89. M. A. Hamburg, "FDA Supports Development of Innovative Genetic Tests," Wall Street Journal, December 3, 2013: http://online.wsj.com/news/articles/ SB10001424052702304011304579222111609444156.

90. F. S. Collins and M. A. Hamburg, "First FDA Authorization for Next-Generation Sequencer," New England Journal of Medicine 369 (2013): 2369–2371.

91. "Regulation of Laboratory Developed Tests (LDTs)," American Society for Clinical Pathology, 2010, http://www.ascp.org/PDF/Advocacy/Regulation-of-laboratory-developed-tests-LDTs.aspx.

92. P. Offt, Do You Believe in Magic? (New York, NY: HarperCollins, 2013).

93. A. O'Connor, "Spike in Harm to Liver Is Tied to Dietary Aids," New York Times, December 22, 2013, http://www.nytimes.com/2013/12/22/us/spike-in-harm-to-liver-is-tied-to-dietary-aids.html.